Literature DB >> 24515993

Trends in cause of death after percutaneous coronary intervention.

Daniel B Spoon1, Peter J Psaltis, Mandeep Singh, David R Holmes, Bernard J Gersh, Charanjit S Rihal, Ryan J Lennon, Issam D Moussa, Robert D Simari, Rajiv Gulati.   

Abstract

BACKGROUND: The impact of changing demographics on causes of long-term death after percutaneous coronary intervention (PCI) remains incompletely defined. METHODS AND
RESULTS: We evaluated trends in cause-specific long-term mortality after index PCI performed at a single center from 1991 to 2008. Deaths were ascertained by scheduled prospective surveillance. Cause was determined via telephone interviews, medical records, autopsy reports, and death certificates. Competing-risks analysis of cause-specific mortality was performed using 3 time periods of PCI (1991-1996, 1997-2002, and 2003-2008). Final follow-up was December 31, 2012. A total of 19 077 patients survived index PCI hospitalization, of whom 6988 subsequently died (37%, 4.48 per 100 person-years). Cause was determined in 6857 (98.1%). Across 3 time periods, there was a 33% decline in cardiac deaths at 5 years after PCI (incidence: 9.8%, 7.4%, and 6.6%) but a 57% increase in noncardiac deaths (7.1%, 8.5%, and 11.2%). Only 36.8% of deaths in the recent era were cardiac. Similar trends were observed regardless of age, extent of coronary disease, or PCI indication. After adjustment for baseline variables, there was a 50% temporal decline in cardiac mortality but no change in noncardiac mortality. The decline in cardiac mortality was driven by fewer deaths from myocardial infarction/sudden death (P<0.001) but not heart failure (P=0.85). The increase in noncardiac mortality was primarily attributable to cancer and chronic diseases (P<0.001).
CONCLUSIONS: This study found a marked temporal switch from predominantly cardiac to predominantly noncardiac causes of death after PCI over 2 decades. The decline in cardiac mortality was independent of changes in baseline clinical characteristics. These findings have implications for patient care and clinical trial design.

Entities:  

Keywords:  cardiovascular diseases; coronary disease; death; percutaneous coronary intervention

Mesh:

Year:  2014        PMID: 24515993     DOI: 10.1161/CIRCULATIONAHA.113.006518

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  34 in total

Review 1.  Gamma-glutamyl transferase and cardiovascular disease.

Authors:  Gjin Ndrepepa; Adnan Kastrati
Journal:  Ann Transl Med       Date:  2016-12

2.  Prolonged dual antiplatelet therapy after drug-eluting stenting: meta-analysis of randomized trials.

Authors:  Salvatore Cassese; Robert A Byrne; Gjin Ndrepepa; Heribert Schunkert; Massimiliano Fusaro; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2015-04-23       Impact factor: 5.460

3.  Interventional cardiology: Causes of death after PCI.

Authors:  Gregory B Lim
Journal:  Nat Rev Cardiol       Date:  2014-02-25       Impact factor: 32.419

Review 4.  Thrombus aspiration in acute myocardial infarction.

Authors:  Karim D Mahmoud; Felix Zijlstra
Journal:  Nat Rev Cardiol       Date:  2016-03-10       Impact factor: 32.419

Review 5.  Cancer Event Rate and Mortality with Thienopyridines: A Systematic Review and Meta-Analysis.

Authors:  Rafail Angelos Kotronias; Chun Shing Kwok; Chun Wai Wong; Tim Kinnaird; Azfar Zaman; Mamas A Mamas
Journal:  Drug Saf       Date:  2017-03       Impact factor: 5.606

Review 6.  Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis.

Authors:  Sammy Elmariah; Laura Mauri; Gheorghe Doros; Benjamin Z Galper; Kelly E O'Neill; Philippe Gabriel Steg; Dean J Kereiakes; Robert W Yeh
Journal:  Lancet       Date:  2014-11-16       Impact factor: 79.321

7.  2016 Revision of the SCAI position statement on public reporting.

Authors:  Lloyd W Klein; Kishore J Harjai; Fred Resnic; William S Weintraub; H Vernon Anderson; Robert W Yeh; Dmitriy N Feldman; Osvaldo S Gigliotti; Kenneth Rosenfeld; Peter Duffy
Journal:  Catheter Cardiovasc Interv       Date:  2016-11-10       Impact factor: 2.692

8.  Nutritional State Predicts All-Cause Death Independent of Comorbidities in Geriatric Patients with Coronary Artery Disease.

Authors:  B-T Huang; Y Peng; W Liu; C Zhang; H Chai; F-Y Huang; Z-L Zuo; Y-B Liao; T-L Xia; M Chen
Journal:  J Nutr Health Aging       Date:  2016-02       Impact factor: 4.075

9.  Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials.

Authors:  Christoph B Olivier; Vandana Sundaram; Deepak L Bhatt; Sergio Leonardi; Renato D Lopes; Victoria Y Ding; Lingyao Yang; Gregg W Stone; Ph Gabriel Steg; C Michael Gibson; Christian W Hamm; Matthew J Price; Harvey D White; Manisha Desai; Donald R Lynch; Robert A Harrington; Kenneth W Mahaffey
Journal:  Int J Cardiol       Date:  2018-06-08       Impact factor: 4.164

10.  Causes of late mortality with dual antiplatelet therapy after coronary stents.

Authors:  Laura Mauri; Sammy Elmariah; Robert W Yeh; Donald E Cutlip; P Gabriel Steg; Stephan Windecker; Stephen D Wiviott; David J Cohen; Joseph M Massaro; Ralph B D'Agostino; Eugene Braunwald; Dean J Kereiakes
Journal:  Eur Heart J       Date:  2015-11-18       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.